Clinical Trials
796 Ovarian Cancer Trials Are Recruiting Right Now
A data-driven look at the clinical trial landscape for ovarian cancer. Where the trials are, what they're testing, and how to find one near you.
Talc-Related Cancer Clinical Trials
Every Trial. Every Doctor.
One Place.
Track clinical trials for ovarian cancer and mesothelioma in real time. Find specialists who treat these talc-related cancers. Follow the research that matters.
796 Active Trials
65 Countries
2 Cancers Tracked
25+ US States
Two Cancers. One Resource.
Talc and asbestos exposure are linked to both ovarian cancer and mesothelioma. TalcTrials tracks clinical trials, research, and specialists for both.
Ovarian Cancer
796 active trials
PARP inhibitors, immunotherapy, ADCs, and targeted therapy. Trials recruiting for all stages and subtypes.
- PARP Inhibitors
- Immunotherapy
- Antibody-Drug Conjugates
- Chemotherapy Combinations
Mesothelioma
100+ active trials
Immunotherapy, gene therapy, multimodal treatment, and surgical advances. Trials for pleural and peritoneal mesothelioma.
- Immunotherapy (Opdivo + Yervoy)
- Gene Therapy
- Surgery + HIPEC
- Radiation + Chemo
What TalcTrials Tracks
Live data from ClinicalTrials.gov, updated daily. Research news from published studies and FDA actions.
Clinical Trials
Every recruiting trial for ovarian cancer and mesothelioma. Filtered by treatment type, phase, and location. 796 trials tracked.
Specialist Directory
Gynecologic oncologists and mesothelioma specialists across the US. Filtered by location, institution, and trial involvement.
Research News
Drug approvals, trial results, conference data. The developments that matter for treatment decisions.
Treatment Guides
Evidence-based guides for patients. Written in plain language, sourced from peer-reviewed research and NCI data.
Latest Research & News
View all → 
Treatment Advances
PARP Inhibitors Changed Ovarian Cancer Treatment
Olaparib, niraparib, rucaparib. How a new class of drugs extended progression-free survival to 40 months for some patients.
Talc Litigation
Philadelphia Jury Orders J&J to Pay $250K in Talc Verdict
Another jury finds Johnson & Johnson liable. What the latest talc ovarian cancer verdict means for pending cases.
Treatment Categories We Track
Active trials organized by treatment approach. Covering both ovarian cancer and mesothelioma.